Illumina and IDbyDNA Launch DNA Test That May Find Next Epidemic

Oct. 15, 2020, 11:45 AM

Illumina Inc. and its partner, venture capital-backed IDbyDNA Inc., are introducing a new test that can tell if someone is infected with Covid-19, the flu or another respiratory disease. It could also be an early warning system for the next epidemic.

The testing panel will use Illumina’s next-generation sequencing, the same technology used for the human genome, and will test for almost 300 pathogens.

IDbyDNA provides the bioinformatics software to analyze the data. The test, called Respiratory Pathogen ID/AMR Target Enrichment Panel, will be made available for research purposes only. If there are plans to expand into commercial markets, ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.